Key result
Serum from patients with primary and secondary hyperlipemia inhibited the clearing activity present in normal serum after intravenous administration of heparin.
Why the study?
Does intravenous heparin cause less lipemia clearing activity in patients with hyperlipemia compared to normal controls?
Observational
Does intravenous heparin cause less lipemia clearing activity in patients with hyperlipemia compared to normal controls?
Serum from hyperlipemic patients inhibits the lipemia clearing activity induced by intravenous heparin, suggesting a mechanism for impaired lipid clearance in these patients.
Answers are grounded in this paper and cite their sources.
May indicate serum inhibitors of heparin lipemia clearance in hyperlipemia; hypothesis-generating and leaves open clinical relevance.
Summary1. Serum from patients with primary and secondary hyperlipemia was found to inhibit the clearing activity present in normal serum after intravenous administration of heparin. 2. The degree of inhibition exerted by the hyperlipemic sera varied among the patients, but at appropriate concentrations of hyperlipemic serum complete inhibition could be attained in every case. 3. Intravenous administration of heparin caused considerably less clearing activity in hyperlipemic patients than in the control subjects.
No takes yet. Share an insight, caveat, or question.
Klein et al. (1957) conducted an observational in Primary and secondary hyperlipemia. Hyperlipemic serum vs. Normal serum / control subjects was evaluated on Clearing activity after intravenous administration of heparin. Serum from patients with primary and secondary hyperlipemia inhibited the clearing activity present in normal serum after intravenous administration of heparin.
Synapse has enriched 10 related papers. Consider them for comparative context: